期刊文献+

FoxP3^+CD4^+CD25^+调节性T细胞在重症肌无力发病机制中的作用 被引量:4

The role of FoxP3^+CD4^+CD25^+ T cells in the pathogenesis of myasthenia gravis
下载PDF
导出
摘要 目的在细胞与分子水平检验重症肌无力(myasthenia gravis,MG)患者外周血中CD4+CD25+调节性T细胞(CD4+CD25+Tregs)的表达缺陷,探讨CD4+CD25+Tregs亚群异常与MG发病间的关系。方法流式细胞技术检测21例MG患者(11例经胸腺切除)与20名健康对照者(healthy controls,HCs)外周血CD4+ CD25+ Tregs及FoxP3+CD4+CD25+Tregs含量,实时荧光定量聚合酶链反应(RT-FQ-PCR)分析MG患者与HCs外周血CD4+CD25+Tregs中FoxP3mRNA的表达。结果MG患者外周血CD4+ CD25+Tregs占CD4+T细胞含量与HCs比较无统计学差异(P>0.05)。MG患者外周血FoxP3+CD4+CD25+ Tregs含量及FoxP3mRNA表达量与HCs比较均显著性降低(P<0.05);胸腺切除的MG患者与未经胸腺切除的MG患者外周血FoxP3+CD4+CD25+Tregs含量及FoxP3 mRNA表达量无统计学差异(P>0.05)。结论MG患者外周血CD4+CD25+Tregs数量正常,但其表面分子FoxP3的表达下调,这种CD4+CD25+Tregs亚群的异常发现有助于深入阐明MG的免疫发病机制。 Objective To identify the expression defects of CD4 ^+ CD25 ^+ regulatory T cells ( CD4 ^+ CD25 ^+ Tregs) in peripheral blood from myasthenia gravis (MG) patients at the cellular and molecular levels, with special focus on the effect of thymectomy on CD4 ^+ CD25 ^+ Tregs, and to investigate the relationship between the abnormalities of CD4 ^+ CD25 ^+ Tregs subset and the onset of MG. Methods Peripheral blood samples were obtained from 21 MG patients ( 11 patients have been thymectomized) and 20 healthy controls ( HCs), flow cytometry was used to analyze the number of CD4 ^+ CD25 ^+ Tregs and FoxP3 ^+ CD4 ^+ CD25 ^+ Tregs and real-time fluorescent quantitative ioolymerase chain reaction (RT-FQ-PCR) was used to determine the FoxP3 mRNA level of CD4 ^+ CD25 ^+ Tregs. Results There were no differences in the percentages of CD4 ^+ CD25 ^+ Tregs among CD4 ^+ T cells between MG patients and HCs ( P 〉 0. 05 ), the FoxP3-positive CD4 ^+ CD25 ^+ Tregs (FoxP3 ^+ CD4 ^+ CD25 ^+ Tregs) and the mRNA expression of FoxP3 were significantly different in CD4 ^+ CD25 ^+ Tregs of MG patients as compared to HCs ( P 〈 0. 05 ) ; the frequencies of CD4 ^+ CD25 ^+ Tregs and the expression of FoxP3 were similar in MG patients irrespective of treatment with thymectomy ( P 〉 0. 05 ). Conclusions The number of the CD4 ^+ CD25 ^+ Tregs is normal in MG patients, but the expression of their surface molecule Foxp3 is decreased. The abnormal finding on the CD4 ^+ CD25 ^+ Tregs subset could contribute to further elucidate the immunologic pathogenesis in MG.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2007年第8期467-471,共5页 Chinese Journal of Nervous and Mental Diseases
基金 国家自然科学基金资助项目(编号:30470583)
关键词 重症肌无力 CD4+CD25+调节性T细胞 FOXP3 Myasthenia gravis CD4^+ CD25 ^+ regulatory T cells FoxP3
  • 相关文献

参考文献12

  • 1Kleer IM,Wedderburn LR,Taams LS,et al.CD4^+ CD25^bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.J Immunol,2004,172(10):6435.
  • 2Karube K,Ohshima K,Tsuchiya T,et al.Expression of FoxP3,a key molecule in CD4CD25 regulatory T cells,in adult T-cell leukaemia/lympboma cells.Br J Haematol,2004,126(1):81.
  • 3Sugiyama H,Gyulai R,Toichi E,et al.Dysfunctional blood and target tissue CD4 + CD25 high regulatory T cells in psoriasis:mechanism underlying unrestrained pathogenic effector T cell proliferation.J Immunol,2005,174(1):164.
  • 4刘银红,许贤豪,崔丽英,秦绍森,王湘.胸腺切除术对重症肌无力患者电生理学指标和临床评分的影响[J].中国神经精神疾病杂志,2006,32(1):8-10. 被引量:7
  • 5Takahama Y.Journey through the thymus:stromal guides for T-cell development and selection.Nat Rev Immunol,2006,6 (2):127.
  • 6Sakaguchi S.Naturally arising CD4^+ regulatory T cells for immunologic self-tolerance and negative control of immune responses.Annu Rev Immunol,2004,22(4):531.
  • 7Asano M,Toda M,Sakaguchi N,et al.Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.J Exp Med,1996,184(2):387.
  • 8Karim M,Kingsley CI,Bushell AR,et al.Alloantigen-induced CD25^+ CD4^+ regulatory T cells can develop in vivo from CD25^-CD4^+ precursors in a thymus-independent process.J Immunol,2004,172(2):923.
  • 9Morgan ME,van Bilsen JH,Bakker AM,et al.Expression of FoxP3 mRNA is not confined to CD4^+ CD25^+ T regulatory cells in humans.Hum Immunol,2005,66(1):13.
  • 10Foussat A,Cottrez F,Brun V,et al.A comparative study between T regulatory type 1 and CD4^+ CD25^+ T cells in the control of inflammation.J Immunol,2003,171 (10):5018.

二级参考文献8

  • 1Lanska DJ. Indications for thymectomy in myasthenia gravis. Neurology, 1990, 40(12):1828.
  • 2Sitzer G, Brune GG. Effect of cholinesterase inhibitors and thymectomy on single - fiber EMG in myasthenia gravis. Ann NY Acad Sci,1981,377(8):884.
  • 3Gronseth S, Barohn RJ. Practice parameters: thymectomy for autoimmune myasthenia gravis (an evidence base review ). Neurology,2000, 55(1):7.
  • 4Jaretzki Ⅲ A, Steinglass KM, Sonett JR. Thymectomy in the management of myasthenia gravis. Seminars in Neurology, 2004,24(1):49.
  • 5Liu Wei, Tong Ti, Ji ZhengDong, et al. Long - term prognostic analysis of thymectomized patients with myasthenia gravis. Chinese Medical Journal, 2002,115(2): 235.
  • 6许贤豪.重症肌无力[M]//许贤豪主编.肌无力-临床与基础.北京:中国协和医科大学出版社,2003:46-75.
  • 7崔丽英,汤晓芙,周瑞玲,李本红,杜华.单纤维肌电图正常值的研究[J].中华神经科杂志,1999,32(1):28-30. 被引量:38
  • 8高枫.重症肌无力免疫治疗研究的进展[J].中国神经精神疾病杂志,1999,25(4):256-256. 被引量:1

共引文献6

同被引文献29

  • 1毛海婷,王雄彪,张玲,顾洪涛.CTLA-4在重症肌无力患者中的表达及其多态性导致的无效转录研究[J].中华微生物学和免疫学杂志,2005,25(4):257-262. 被引量:6
  • 2Shevach EM, McHugh RS, Piccirillo CA, et al. Control of T cell activation by CD4 + CD25 + suppressor T cells . Immunol Rcv, 2001,182:58-74.
  • 3Lan RY, Ansari AA, Lian ZX, et al. Regulation T cell: development, function and role in autoimmunity. Autoimmun Rev, 2005,4:351-363.
  • 4Khattri R, Cox T, Yasayko SA, et al. An essential role for Scurfin in CD4+ CD25 + regulatory T cells. Nat Immunol,2003,4:337- 342.
  • 5Takahashi T, Kuniyasu Y, Toda M, et al. Immunologic self- tolerance maintained by CD25 + CD4+ naturally anergic and suppressive T ceils: induction of autoimmune disease by breaking their anergic /suppressive state. Int Immunol, 1998, 10: 1969- 1980.
  • 6Andrea F, Alessandra B, Alexia B, et al. Circulating and thymic CD4^+ CD25^+ T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology, 2005, 116: 134- 141.
  • 7Huang Y, Pirskanen R, Giscombe R, et al. Circulating CD4 + CD25 + T cells in myasthenia gravis and in relation to thymectomy. Scand J Immunol,2004 ,59:408-414.
  • 8Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory Tcells . ImmunolRev,2001, 182:190- 200.
  • 9Jordan M, Boesteanu A, Reed A, et al. Thymicselectio of CD4 + CD25 + regulatory T cells induced by anagonist self peptide. Nat Immunol,2001,2 : 301-306.
  • 10Levinson AI, Zheng Y, Caulton G, et al. Intrathymic expression of neuromuscular acetylcholine receptor and the immunpathgenesis of myasthenia gravis [ J ], Immunol Res ,2003 ,27 (2 - 3 ) :399 - 408.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部